-
- 三輪 恕昭
- 岡山大学医学部第1外科
書誌事項
- タイトル別名
-
- EFFECT OF IMMUNOCHEMOTHERAPY WITH LEVAMISOLE ON GASTRIC CANCER PATIENTS
説明
To 84 gastric cancer patients levanisole (LMS) was given starting three days before gastrectomy, at a doses of 150mg/day for three consecutive days every other week for as long as possible. And the survival rates of LMS group were compared with those of the historical control group. In the stage III gastric cancer patients the back ground factors of the both groups were matched as closely as possible. Both groups were concomitantly treated with mitomycin C and FT-207.<br> The survival rate of the LMS group was significantly higher than that of the control group (p<0.05). In the stage III gastric cancer patients the survival rates of the LMS group were significantly higher than those of the control group (p<0.05) when curative resection was performed, the tumor had a diameter of 4.0-8.0cm, there were metastases within the regional lymph nodes (n1), cancer cells infiltrated to the gastric serosa (se), cancer cells were not involved in the venous channels (V0) and they were slightly involved in the lymphatic channels (ly1).
収録刊行物
-
- 日本臨床外科医学会雑誌
-
日本臨床外科医学会雑誌 46 (8), 1051-1056, 1985
日本臨床外科学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001205304667264
-
- NII論文ID
- 130003596191
-
- ISSN
- 21892075
- 03869776
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可